CareDxvsJohnson & Johnson

CDNA and JNJ stock compared: price, dividend, valuation and results, from SEC filings.

CareDx (CDNA) has a market value of $3.8B and Johnson & Johnson (JNJ) $681B. Over the last year, with dividends, CDNA moved +362.5% and JNJ +47.5%. The P/E is 29.4 for CDNA and 42.3 for JNJ. Dividend yield: CDNA none, JNJ 1.87%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    CDNA$3.8B

    JNJ$681B

    JNJ is 180 times CDNA

  • Revenue, 12 months

    CDNA$497M

    JNJ$99.3B

    JNJ is 200 times CDNA

  • Net income, 12 months

    CDNA$129M

    JNJ$16.1B

    JNJ is 125 times CDNA

  • Operating margin

    CDNA23.4%

    JNJ–

  • ROIC

    CDNA25.3%

    JNJ12.4%

    12.9 points apart

  • P/E

    CDNA29.4

    JNJ42.3

    JNJ is 1.4 times CDNA

  • Dividend yield

    CDNA0.0%

    JNJ1.9%

    1.9 points apart

  • 5-year return

    CDNA+56.9%

    JNJ+98.6%

    41.7 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

CDNA+56.9%

JNJ+98.6%

010020020222023202420252026
Returns by period
PeriodCDNAWith dividendsJNJWith dividends
1 year since November 14, 2025+362.5%Price +362.5%+47.5%Price +44.2%
3 years since November 16, 2023+707.4%+100.6% a yearPrice +707.4%+105.0%+27.0% a yearPrice +88.2%
5 years since November 15, 2021+56.9%+9.4% a yearPrice +56.9%+98.6%+14.7% a yearPrice +72.8%
10 years since November 17, 2016+2,168.3%+36.6% a yearPrice +2,168.3%+218.0%+12.3% a yearPrice +142.4%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

CDNACareDxJNJJohnson & Johnson

Valuation

CDNAJNJ
Valuation
Price$73.72$282.55
Market value$3.8B$681B
Enterprise value (EV)$3.5B$708B
P/E29.442.3
P/E, 5-year median–21.9
P/B8.18.4
EV/EBIT30.339.9
Free cash flow yield–3.0%

Results and growth

CDNAJNJ
Results and growth
Revenue, 12 months$497M$99.3B
Net income, 12 months$129M$16.1B
Free cash flow, 12 months–$20.6B
Earnings per share, 12 months$2.39$6.59
Revenue growth, year on year13.8%6.1%
Revenue growth a year, past+14.6%over 5 years+2.7%over 5 years
EPS growth a year, past–+14.9%over 5 years

Margins and returns on capital

CDNAJNJ
Margins and returns on capital
Gross margin–67.6%
Operating margin23.4%–
Net margin25.9%16.2%
ROIC25.3%12.4%
ROE35.3%19.7%

Balance sheet

CDNAJNJ
Balance sheet
Cash$250M$17.2B
Total debt$29M$44.7B
Net debt / EBITDA-1.91.1
Interest cover–18.0×

Dividends and buybacks

CDNAJNJ
Dividends and buybacks
Dividend yield–1.9%
Dividend per share, 12 months–$5.28
Dividend growth a year, past–+5.3%over 5 years
Buyback yield2.3%0.9%
Shareholder yield2.3%2.7%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: CDNA or JNJ

Didn't find what you were looking for?

Ask us
Which is bigger, CareDx or Johnson & Johnson?

By market value, Johnson & Johnson ($681B) is about 180.3 times CareDx ($3.8B), at today's prices.

How did CDNA and JNJ stock do over the last 10 years?

Since November 17, 2016, CDNA's price moved +2,168.3% and JNJ's +142.4%. With dividends: CDNA +2,168.3% (+36.6% a year), JNJ +218.0% (+12.3% a year). Past returns do not predict future ones.

Which pays the higher dividend, CDNA or JNJ?

The dividend yield at today's price is none for CareDx and 1.87% for Johnson & Johnson. Over the last twelve months they paid – and $5.28 per share.

What is the P/E of CDNA and JNJ?

At today's price, the P/E is 29.4 for CDNA and 42.3 for JNJ. It is the share price over the last twelve months' earnings per share.

Which has the higher profit margins, CareDx or Johnson & Johnson?

Over the last twelve months, the net margin was 25.9% for CareDx and 16.2% for Johnson & Johnson, and the operating margin 23.4% and –. Revenue was $497M and $99.3B.

Which is the better investment, CareDx or Johnson & Johnson?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.